Rapid reduction of mycophenolate mofetil and calcineurin inhibitor dose for treating cytomegalovirus infection in renal transplant patients.

被引：0
|
作者：
Lin, Kuo Jen [1 ]
Wang, Hsu-Han [1 ]
Lin, Chih-Te [1 ]
Pan, Pai-Yen [1 ]
Chen, Sy-Yuan [1 ]
机构：
[1] Chang Gung Mem Hosp, Dept Urol, Linkou Branch, Taoyuan, Taiwan
来源：
TRANSPLANTATION | 2024年 / 108卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P.290
引用
收藏
页码：592 / 592
页数：1
相关论文
共 50 条
  • [1] Calcineurin inhibitor reduction based on maintenance immunosuppression with mycophenolate mofetil in renal transplant patients:: POP study
    Pallardo, L. M.
    Oppenheimer, F.
    Guirado, L.
    Conesa, J.
    Hortal, L. J.
    Romero, R.
    Rivero, M.
    de Bonis, E.
    Muniz, M. L.
    Esforzado, N.
    [J]. TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2187 - 2189
  • [2] Mycophenolate mofetil in liver transplant patients with calcineurin-inhibitor-induced renal impairment
    Ko, Hin Hin
    Greanya, Erica
    Lee, Tim K.
    Steinbrecher, Urs P.
    Erb, Siegfried R.
    Yoshida, Eric M.
    [J]. ANNALS OF HEPATOLOGY, 2008, 7 (04) : 376 - 380
  • [3] Mycophenolate Mofetil in liver transplant patients with calcineurin inhibitor withdrawl
    Zanotelli, ML
    Gleisner, AL
    Fleck, A
    Schlindwein, E
    Cassal, A
    Leipnitz, I
    Grezzana, TD
    Meine, MH
    Hope, L
    Brandao, ADM
    Marroni, CA
    Cantisani, GPC
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 365 - 365
  • [4] Updated metaanalysis of steroid withdrawal in renal transplant patients on calcineurin inhibitor and mycophenolate mofetil
    Pascual, J
    Quereda, C
    Zamora, J
    Hernández, D
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) : 3746 - 3748
  • [5] Efficacy and safety of a reduced calcineurin inhibitor dose combined with mycophenolate mofetil in liver transplant patients with chronic renal dysfunction
    Wang, Pusen
    Que, Weitao
    Li, Hao
    Yan, Lvnan
    Fu, Zhiren
    Ye, Qifa
    Chen, Guihua
    Dou, Kefeng
    Lu, Shichun
    Yang, Zhanyu
    Zhu, Zhijun
    Peng, Zhihai
    Zhong, Lin
    [J]. ONCOTARGET, 2017, 8 (34) : 57505 - 57515
  • [6] The relationship between dose of mycophenolate mofetil and the occurrence of cytomegalovirus infection and diarrhea in renal transplant recipients
    Toda, T
    Motoki, T
    Kurosawa, N
    Owada, E
    Achiwa, K
    Yuhki, Y
    Tadano, K
    Takahashi, Y
    Shimoda, N
    Shindo, J
    Harada, H
    Seki, T
    Hirano, T
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2005, 125 (02): : 177 - 185
  • [7] Benefit of mycophenolate mofetil in immunized renal transplant patients.
    Kliem, V
    vonWoellwarth, J
    Behrend, M
    Schlitt, HJ
    Nashan, B
    Koch, KM
    Pichlmayr, R
    Brunkhorst, R
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3211 - A3211
  • [8] Treatment of calcineurin inhibitor toxicity by dose reduction plus introduction of mycophenolate mofetil
    McKane, W
    Kanganas, C
    Preston, R
    Cairns, T
    Hakim, N
    Palmer, A
    Taube, D
    [J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1224 - 1225
  • [9] Influence of mycophenolate mofetil and calcineurine inhibitor differences on basiliximab pharmacokinetics in renal transplant patients.
    Haba, T
    Uchida, K
    Katayama, A
    Gotoh, N
    Tominaga, Y
    Matsuoka, O
    Satoh, T
    Uno, N
    Takeda, A
    Morozumi, K
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 183 - 183
  • [10] Improvement of renal transplant function by reduction of calcineurin inhibitor and introduction of mycophenolate mofetil acid in patients with chronic allograft nephropathy.
    Merkel, Saskia
    Mengel, Michael
    Haller, Hermann
    Schwarz, Anke
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 533 - 533
12345